Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life

NCT02839291 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Tumor With Bone Metastasis

Interventions

OTHER: quality of life questionaries
DRUG: intravenous or oral bone antiresorptive treatments

Sponsor

Centre Hospitalier Universitaire de Besancon